Abeba Demelash, Ph.D., is a Senior Scientist I at Merck, with over 14 years of experience in translational oncology and histopathology research. Previously, Abeba worked as a Research Scientist at The Cleveland Clinic Foundation, where they led significant studies on chemotherapy resistance and contributed to securing over $1.25 million in NIH grant funding. Abeba possesses expertise in molecular biology, biomarker assays, and cancer therapeutics, having managed multiple projects in both academia and industry. With a strong passion for translating scientific discoveries into therapeutic applications, Abeba continues to advance biomedical research. Abeba holds a Master's Degree in Cellular and Molecular Biology and a Ph.D. in Cell and Molecular Biology from the University of Gothenburg.
This person is not in the org chart
This person is not in any teams
This person is not in any offices